{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:04:03Z","timestamp":1773291843182,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T00:00:00Z","timestamp":1246320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10637-009-9286-9","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T05:08:28Z","timestamp":1246252108000},"page":"670-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma"],"prefix":"10.1007","volume":"28","author":[{"given":"Jennifer","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Feun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Van Veldhuizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence S.","family":"Blaszkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HaoBin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MaryLynn","family":"Nierodzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Hochster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Muggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Abbadessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,30]]},"reference":[{"key":"9286_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer J Clin 58:71\u201396","journal-title":"CA Cancer J Clin"},{"key":"9286_CR2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","volume":"139","author":"HB El-Serag","year":"2003","unstructured":"El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:817\u2013823","journal-title":"Ann Intern Med"},{"key":"9286_CR3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnci\/djg040","volume":"95","author":"HK Weir","year":"2003","unstructured":"Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK (2003) J Natl Cancer Inst 95:1276\u20131299","journal-title":"J Natl Cancer Inst"},{"key":"9286_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Onc 27:1485\u20131491","journal-title":"J Clin Onc"},{"key":"9286_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliverira AD, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J (2008) Sorafenib in advanced hepatocellular carcinoma. NEJM 359:378\u2013390","journal-title":"NEJM"},{"key":"9286_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2008","unstructured":"Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Lou R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z (2008) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet 10:25\u201334","journal-title":"Lancet"},{"key":"9286_CR7","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.3748\/wjg.v10.i24.3677","volume":"10","author":"HY Xu","year":"2004","unstructured":"Xu HY, Yang YL, Liu SM, Bi L, Chen SX (2004) Effect of arsenic trioxide on human hepatocarcinoma in nude mice. World J Gastroenterol 10:3677\u20133679","journal-title":"World J Gastroenterol"},{"key":"9286_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1349-7006.2003.tb01393.x","volume":"94","author":"M Kito","year":"2003","unstructured":"Kito M, Matsumoto K, Wada N, Sera K, Futatsugawa S, Naoe T, Nozawa Y, Akao Y (2003) Antitumor effect of arsenic trioxide in murine xenograft model. Cancer Sci 94:1010\u20131014","journal-title":"Cancer Sci"},{"key":"9286_CR9","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3748\/wjg.v11.i38.5938","volume":"11","author":"B Tan","year":"2005","unstructured":"Tan B, Huang BF, Wei Q, Zhang H, Ni RZ (2005) Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats. World J Gastroenterol 11:5938\u20135943","journal-title":"World J Gastroenterol"},{"key":"9286_CR10","first-page":"61","volume":"22","author":"T Zhang","year":"2003","unstructured":"Zhang T, Wang SS, Hong L, Wang XL, Qi QH (2003) Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo. J Exp Clin Cancer Res 22:61\u201368","journal-title":"J Exp Clin Cancer Res"},{"key":"9286_CR11","first-page":"487","volume":"23","author":"J Qian","year":"2001","unstructured":"Qian J, Qin S, He Z (2001) Arsenic trioxide in the treatment of advanced primary liver and gallbladder cancer. Zhonghua Zhongliu Zazhi 23:487\u2013489","journal-title":"Zhonghua Zhongliu Zazhi"},{"key":"9286_CR12","first-page":"63","volume":"10","author":"J Qian","year":"2002","unstructured":"Qian J, Qin SK, He ZM, Wang L, Chen YX, Shao ZJ, Liu XF (2002) Arsenic trioxide for the treatment of medium and advanced primary liver cancer. Zhonghua Ganzhangbing Zazhi 10:63","journal-title":"Zhonghua Ganzhangbing Zazhi"},{"key":"9286_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10637-007-9034-y","volume":"25","author":"CC Lin","year":"2007","unstructured":"Lin CC, Hsu C, Hsu CH, Hsu W, Cheng AL, Yang CH (2007) Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial. Invest New Drugs 25:73\u201384","journal-title":"Invest New Drugs"},{"key":"9286_CR14","first-page":"691","volume-title":"Casarett and Doull\u2019s toxicology: the basic science of poisons","author":"RA Goyer","year":"1996","unstructured":"Goyer RA (1996) Toxic effects of metals. In: Klassen CD (ed) Casarett and Doull\u2019s toxicology: the basic science of poisons, 5th edn. McGraw-Hill, New York, pp 691\u2013698","edition":"5"},{"key":"9286_CR15","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1200\/JCO.2003.10.009","volume":"21","author":"T Jean","year":"2003","unstructured":"Jean T, Barbey JC, Pezzullo SL (2003) Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Onc 21:3609\u20133615","journal-title":"J Clin Onc"},{"key":"9286_CR16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/187152008786847666","volume":"8","author":"A Quitas-Cardama","year":"2008","unstructured":"Quitas-Cardama A, Verstovsek S, Freireich E, Kantarjian H, Chen YW, Zingaro R (2008) Chemical and clinical development of darinaparsin, a novel organic arsenic derivative. Anticancer Agnets Med Chem 8:904\u2013908","journal-title":"Anticancer Agnets Med Chem"},{"key":"9286_CR17","first-page":"A# 4446","volume":"106","author":"T Manshouri","year":"2005","unstructured":"Manshouri T, Kala SV, Ashoori F, Zingaro R, Frieireich EJ, Andreeff M, Kantarjian HM, Verstovsek S (2005) Comparison of uptake and intracellular induced structural changes of arsenic trioxide, an inorganic compound, and organic arsenic derivative S-dimethylarsino-glutathione in NB4 APL cells. Blood, Proc Ame Soc Hem 106:A# 4446","journal-title":"Blood, Proc Ame Soc Hem"},{"key":"9286_CR18","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/leu.2008.194","volume":"22","author":"Z Diaz","year":"2008","unstructured":"Diaz Z, Mann KK, Marcoux S, Kourelis M, Colombo M, Miller WH (2008) A novel arsenic has anti-tumor activity towards As2O3-resistant and MRP1\/ABCC1-overexpressing cell lines. Leukemia 22:1853\u20131863","journal-title":"Leukemia"},{"key":"9286_CR19","volume-title":"Cancer principles and practice of oncology","author":"VT DeVita","year":"2005","unstructured":"DeVita VT, DeVita VT Jr, Lawrence TS, Rosenberg SA (2005) Cancer principles and practice of oncology, 7th edn. Lippincott Williams And Wilkins, Philadelphia Chapter 24.2, 619","edition":"7"},{"key":"9286_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"9286_CR21","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/carcin\/bgh161","volume":"25","author":"H Chen","year":"2004","unstructured":"Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP (2004) Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25:1779\u20131786","journal-title":"Carcinogenesis"},{"key":"9286_CR22","first-page":"1255","volume":"112","author":"Y Xie","year":"2004","unstructured":"Xie Y, Trouba KJ, Liu J, Waalkes MP, Germolec DR (2004) Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ Health Perspect 112:1255\u20131263","journal-title":"Environ Health Perspect"},{"key":"9286_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbrc.2006.11.001","volume":"352","author":"JF Reichard","year":"2007","unstructured":"Reichard JF, Schnekenburger M, Puga A (2007) Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun 352:188\u2013192","journal-title":"Biochem Biophys Res Commun"},{"key":"9286_CR24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1383-5718(98)00078-3","volume":"415","author":"Y Lee","year":"1998","unstructured":"Lee Y, Broday L, Costa M (1998) Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutation Res 415:213\u2013218","journal-title":"Mutation Res"},{"key":"9286_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1440-1746.2000.02069.x","volume":"15","author":"P Arbuthnot","year":"2000","unstructured":"Arbuthnot P, Capovilla A, Kew M (2000) Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK\/STAT pathways. J Gastroenterol Hepatol 15:357\u2013368","journal-title":"J Gastroenterol Hepatol"},{"key":"9286_CR26","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/00029330-200712020-00004","volume":"120","author":"JH Lei","year":"2007","unstructured":"Lei JH, He XE, Yang X, Zhang M, Lian J, Luo HY, Wang WL (2007) Effects of HBV X gene and arsenic trioxide on the expression of p53 in cultured HepG2 cells. Chin Med J (Engl) 120:2181\u20132184","journal-title":"Chin Med J (Engl)"},{"issue":"15S","key":"9286_CR27","doi-asserted-by":"crossref","first-page":"A#8501","DOI":"10.1200\/jco.2009.27.15_suppl.8501","volume":"27","author":"I Lossos","year":"2009","unstructured":"Lossos I, Craig MS, Tallman RV, Boccia PR, Conkling C, Becerra PB, Komarnitsky B, Hamilton Lewis J, Miller WH (2009) Novel organic arsenic molecule darinaparsin: development of IV and oral forms. J Clin Onc, Proc Am Soc Clin Onc 27(15S):A#8501","journal-title":"J Clin Onc, Proc Am Soc Clin Onc"},{"issue":"18S","key":"9286_CR28","doi-asserted-by":"crossref","first-page":"A#8109","DOI":"10.1200\/jco.2007.25.18_suppl.8109","volume":"25","author":"JR Berenson","year":"2007","unstructured":"Berenson JR, Jaganath S, Reece D, Boccia R, Soebel R, Belch A, Schwartz B, Gale RP, Hussein M (2007) ZIO-101 (S-dimethylarsino-glutathione): phase I\/II trials in advanced\/progressive multiple myeloma. J Clin Onc, Proc Am Soc Clin Onc 25(18S):A#8109","journal-title":"J Clin Onc, Proc Am Soc Clin Onc"},{"key":"9286_CR29","first-page":"A#1966","volume":"108","author":"JR Berenson","year":"2006","unstructured":"Berenson JR, Boccia RVV, Hussein A, Belch A, Boise L, Schwartz B, Gale RP, Kornblau SM (2006) Phase-1 study of ZIO-101: a new organic arsenic active in acute myelogenous leukemia (AML) and multiple myeloma (MM). Blood, Proc Am Soc Hem 108:A#1966","journal-title":"Blood, Proc Am Soc Hem"},{"key":"9286_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1358\/dof.2009.034.02.1337397","volume":"34","author":"C Campas","year":"2009","unstructured":"Campas C, Castaner R (2009) Darinaparsin. Drugs Future 34:97","journal-title":"Drugs Future"},{"key":"9286_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1349-7006.2006.00230.x","volume":"97","author":"B Liu","year":"2006","unstructured":"Liu B, Pan S, Dong X, Qiao H, Jiang H, Krissansen GW, Sun X (2006) Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci 97:675\u2013681","journal-title":"Cancer Sci"},{"key":"9286_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12032-008-9105-8","volume":"26","author":"M Fei","year":"2009","unstructured":"Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S, Ke Q, Liu Y, Li P, Cui X, Shen A, Cheng C (2009) Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization. Med Oncol 26:178\u2013185","journal-title":"Med Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-009-9286-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9286-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-009-9286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:39:49Z","timestamp":1678509589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-009-9286-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,30]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["9286"],"URL":"https:\/\/doi.org\/10.1007\/s10637-009-9286-9","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,30]]},"assertion":[{"value":"21 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}